Koers Boston Therapeutics, Inc. Other OTC
Aandelen
BTHE
US1011501004
Geavanceerde medische apparatuur & technologie
Omzet 2021 | 142K 130K | Omzet 2022 | 15,45K 14,19K | Marktkapitalisatie | 9,32 mln. 8,56 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -9 mln. -8,27 mln. | Nettowinst (verlies) 2022 | -12 mln. -11,02 mln. | EV/omzet 2021 | 149 x |
Nettoschuld 2021 | 4,52 mln. 4,15 mln. | Nettoschuld 2022 | 11,39 mln. 10,46 mln. | EV/omzet 2022 | 1.340 x |
K/w-verhouding 2021 |
-1,75
x | K/w-verhouding 2022 |
-0,62
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 42,05% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Ludvigson
CEO | Chief Executive Officer | 74 | - |
Director of Finance/CFO | - | 19-01-23 | |
Bradley Johnson
CTO | Chief Tech/Sci/R&D Officer | - | 01-11-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jerry Fiddler
BRD | Director/Board Member | 72 | - |
Chairman | 69 | - | |
David Ludvigson
CEO | Chief Executive Officer | 74 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,80% | 34,16 mld. | |
+24,92% | 8,13 mld. | |
+36,69% | 4,44 mld. | |
-28,70% | 2,7 mld. | |
-20,62% | 1,37 mld. | |
-28,50% | 1,27 mld. | |
-32,48% | 1,18 mld. | |
+12,29% | 1 mld. | |
-37,86% | 870 mln. |